Related by context. Frequent words. (Click for all words.) 59 BioMarin Genzyme LLC 59 ZALBIN 58 Gemzar ® 55 plus gemcitabine 54 OLEPTRO TM 54 ONTAK 53 elotuzumab 53 mucopolysaccharidosis VI MPS VI 52 3Q FY# 52 plus prednisone 51 Interest Income Expense 50 TPIAO 50 Pretax Income 50 Including discontinued operations 50 YTD Fiscal 50 Elestat 49 Interest expense decreased 49 Normalized EBITDA 49 Nonperforming assets totaled 49 Ps.2 49 AVINZA 49 Non GAAP adjusted EBITDA 48 Q2 FY# [001] 48 Lilly ICOS 48 RMB1 #.# 48 RITUXAN 47 chlorambucil 47 marketable securities totaled 47 Ps.1 47 Rosetta dependence 46 Novogyne 45 Ps.#.# [002] 45 Posted -# sec 45 Interest Expense Net 45 Adverse events 45 omecamtiv mecarbil 44 apaziquone 44 PTOI 44 Secondary endpoints include 44 EBIT amounted 44 Segment Profit 44 totaled Ps 44 ridaforolimus 44 NET REVENUES 44 aflibercept 43 Detailed breakdowns 43 pershare 43 intersegment eliminations 43 Unaudited Condensed Consolidated 43 Fully diluted earnings 43 - Operating [030] 43 income allocable 43 custirsen 43 Belinostat 42 Pro Forma Adjusted EBITDA 42 INCOME LOSS BEFORE INCOME 42 - Operating [007] 41 adjusted distributable cash 41 Fully compatible 41 OIBDAN 41 - Operating [028] 41 - Operating [012] 41 principally attributable 41 Adjusted Diluted EPS 40 condensed consolidated 40 - Operating [025] 40 - OperatiMcGrath RentCorp 40 Median survival 40 - Operating [015] 40 Core FFO 40 Aldurazyme 40 Adjusted pro forma 40 per MCFE 40 INCOME FROM CONTINUING OPERATIONS 40 Ps.# [001] 39 - Operatinluddites 39 - Net [030] 39 Unaudited Unaudited Audited 39 Income Loss Before 39 - NeDEFENDERS 39 - Net [004] 39 Segment EBIT 39 Noninterest expenses 39 - Operating [019] 39 EGFR targeting 39 - Operating [004] 39 No. #R 39 - Operating [009] 39 unfavorable variance 39 Expense Income 39 c Represents 39 - OCBSO 38 GVAX immunotherapy 38 unallocated corporate 38 - Income [011] 38 GDP shrank 38 Restructuring Charges 38 to#.# [006] 38 Gross profit 38 Excluding autos retail 38 OPERATING ACTIVITIES